Sjur Humerfelt - Publications

Affiliations: 
1988-1994 Department of clinical medicine K2 University of Bergen, Bergen, Hordaland, Norway 
Area:
Asthma, COPD

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hilde JM, Hisdal J, Skjørten I, Hansteen V, Melsom MN, Grøtta OJ, Småstuen MC, Seljeflot I, Arnesen H, Humerfelt S, Steine K. Left ventricular dysfunction in COPD without pulmonary hypertension. Plos One. 15: e0235075. PMID 32673327 DOI: 10.1371/Journal.Pone.0235075  0.328
2018 Skjørten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S. Exercise capacity in COPD patients with exercise-induced pulmonary hypertension. International Journal of Chronic Obstructive Pulmonary Disease. 13: 3599-3610. PMID 30464443 DOI: 10.2147/Copd.S161175  0.331
2018 Skjørten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S. Cardiopulmonary exercise test and PaO in evaluation of pulmonary hypertension in COPD. International Journal of Chronic Obstructive Pulmonary Disease. 13: 91-100. PMID 29339921 DOI: 10.2147/Copd.S150034  0.357
2016 Hilde JM, Skjørten I, Hansteen V, Melsom MN, Atar D, Hisdal J, Humerfelt S, Steine K. Assessment of Right Ventricular Afterload in COPD. Copd. 13: 176-85. PMID 26914261 DOI: 10.3109/15412555.2015.1057275  0.373
2015 Gulsvik AK, Henriksen AH, Svendsen E, Humerfelt S, Gulsvik A. Validity of the European short list of respiratory diseases: A 40-year autopsy study European Respiratory Journal. 45: 953-961. PMID 25359344 DOI: 10.1183/09031936.00085214  0.515
2014 Wang Y, Stavem K, Dahl FA, Humerfelt S, Haugen T. Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). International Journal of Chronic Obstructive Pulmonary Disease. 9: 99-105. PMID 24477272 DOI: 10.2147/Copd.S51467  0.364
2014 Hewitt S, Humerfelt S, Søvik TT, Aasheim ET, Risstad H, Kristinsson J, Mala T. Long-term improvements in pulmonary function 5 years after bariatric surgery Obesity Surgery. 24: 705-711. PMID 24435516 DOI: 10.1007/S11695-013-1159-9  0.355
2013 Hilde JM, Skjørten I, Grøtta OJ, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, Steine K. Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. Journal of the American College of Cardiology. 62: 1103-1111. PMID 23831444 DOI: 10.1016/J.Jacc.2013.04.091  0.359
2013 Skjørten I, Hilde JM, Melsom MN, Hansteen V, Steine K, Humerfelt S. Pulmonary artery pressure and PaO2 in chronic obstructive pulmonary disease. Respiratory Medicine. 107: 1271-9. PMID 23768734 DOI: 10.1016/J.Rmed.2013.03.021  0.371
2013 Gulsvik R, Skjørten I, Undhjem K, Holø L, Frostad A, Saure EW, Lejlic V, Humerfelt S, Hansen G, Bruun Wyller T. Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis. The Clinical Respiratory Journal. 7: 390-6. PMID 23578004 DOI: 10.1111/Crj.12025  0.66
2013 Wang Y, Stavem K, Humerfelt S, Dahl FA, Haugen T. Readmissions for COPD: propensity case-matched comparison between pulmonary and non-pulmonary departments. The Clinical Respiratory Journal. 7: 375-81. PMID 23347439 DOI: 10.1111/Crj.12018  0.361
2013 Hilde JM, Skjørten I, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, Steine K. Haemodynamic responses to exercise in patients with COPD. The European Respiratory Journal. 41: 1031-41. PMID 22903957 DOI: 10.1183/09031936.00085612  0.362
2013 Skjørten I, Hilde JM, Melsom MN, Hansteen V, Steine K, Humerfelt S. Pulmonary hypertension in COPD; the importance of PaO2 Respiratory Medicine. 107. DOI: 10.1016/J.Rmed.2013.08.023  0.337
2012 Gulsvik AK, Gulsvik A, Skovlund E, Thelle DS, Mowé M, Humerfelt S, Wyller TB. The association between lung function and fatal stroke in a community followed for 4 decades. Journal of Epidemiology and Community Health. 66: 1030-6. PMID 22493479 DOI: 10.1136/Jech-2011-200312  0.482
2008 Gulsvik A, Humerfelt S, Bakke PS, Omenaas ER, Lehmann S. Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates. The Clinical Respiratory Journal. 2: 10-25. PMID 20298346 DOI: 10.1111/J.1752-699X.2008.00080.X  0.679
2007 Gulsvik A, Myrseth SE, Henrichsen SH, Humerfelt S, Omenaas E. Increased awareness of COPD in the Norwegian population. The Clinical Respiratory Journal. 1: 118-9. PMID 20298291 DOI: 10.1111/J.1752-699X.2007.00026.X  0.66
2006 Lehmann S, Bakke PS, Eide GE, Humerfelt S, Gulsvik A. Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist. Pulmonary Pharmacology & Therapeutics. 19: 272-80. PMID 16169762 DOI: 10.1016/J.Pupt.2005.07.006  0.644
2001 Gulsvik A, Tosteson T, Bakke P, Humerfelt S, Weiss ST, Speizer FE. Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. Clinical Physiology (Oxford, England). 21: 648-60. PMID 11722472 DOI: 10.1046/J.1365-2281.2001.00377.X  0.621
2001 Gulsvik A, Beckett LA, Bakke P, Humerfelt S, Omenaas E, Speizer FE. Standardized submaximal exercise testing in never smokers: A normative study Clinical Physiology. 21: 629-636. PMID 11576165 DOI: 10.1046/J.1365-2281.2001.00363.X  0.686
1998 Humerfelt S, Eide GE, Gulsvik A. Association of years of occupational quartz exposure with spirometric airflow limitation in Norwegian men aged 30-46 years. Thorax. 53: 649-55. PMID 9828850 DOI: 10.1136/Thx.53.8.649  0.525
1998 Humerfelt S, Eide GE, Kvåle G, Gulsvik A. Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) variability in asymptomatic never-smoking men. Clinical Physiology (Oxford, England). 18: 387-96. PMID 9715766 DOI: 10.1046/J.1365-2281.1998.00115.X  0.552
1998 Humerfelt S, Eide GE, Kvåle G, Aarø LE, Gulsvik A. Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposure. The European Respiratory Journal. 11: 284-90. PMID 9551726 DOI: 10.1183/09031936.98.11020284  0.527
1995 Humerfelt S, Eide GE, Kvåle G, Gulsvik A. Predictors of spirometric test failure: a comparison of the 1983 and 1993 acceptability criteria from the European Community for Coal and Steel. Occupational and Environmental Medicine. 52: 547-53. PMID 7663642 DOI: 10.1136/Oem.52.8.547  0.523
1992 Gulsvik A, Bakke P, Humerfelt S, Omenaas E, Tosteson T, Weiss ST, Speizer FE. Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. Thorax. 47: 167-73. PMID 1519193 DOI: 10.1136/Thx.47.3.167  0.679
Show low-probability matches.